The Patent Finder
US

Mirnas as Biomarkers for Distinguishing Benign from Malignant Thyroid Neoplasms

US 10,150,999 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Nov 10, 2014 (Redpath Equityholder Representative, LLC).

Term ends Nov 17, 2031 · High confidence

Filed Nov 17, 2011 as application 13/299,226 · Granted Dec 11, 2018
Base term, 20 years from filing
Today
20 years from filing
2011 2031
Clock starts
Nov 17, 2011
Term ends
Nov 17, 2031
Granted
Dec 11, 2018
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 17, 2011, when this application, 13/299,226, was filedNov 17, 2031High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 17, 2031High confidence

This family

US 10,150,999this patent
Nov 2031
Nov 2031
US 11,118,231In force
Nov 2031
Nov 2031
Application 17/400,660Abandoned
not computed
not computed
Application 18/815,470Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 21, 2012
Reel 27572, frame 401
Beaudenon-huibregtse, Sylvie; Choudhary, AshishAsuragen, Inc.Assignment of Assignor's Interest
Aug 25, 2014
Reel 33605, frame 803
Asuragen, Inc.Interpace Diagnostics, LLCAssignment of Assignor's Interest
Nov 4, 2014
Reel 34103, frame 278
Interpace Diagnostics, LLCSWK Funding LLC, as AgentSecurity Interest
Nov 10, 2014
Reel 34136, frame 60
Interspace Diagnostics, LLC; JS Genetics, Inc.; Group Dca, LLC; Pdi, Inc.Redpath Equityholder Representative, LLCSecurity Interest
Feb 22, 2016
Reel 37784, frame 629
SWK Funding LLCInterpace Diagnostics LLCRelease of Security Interest
Sep 23, 2016
Reel 40125, frame 251
Pdi, Inc.; Group Dca, LLC; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; JS Genetics, Inc.; Redpath Acquisition Sub, Inc.Redpath Equityholder Representative, LLCGuarantee and Collateral Agreement
Sep 23, 2016
Reel 40127, frame 18
Interpace Diagnostics Corporation; Pdi, Inc.; Group Dca, LLC; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; JS Genetics, Inc.Redpath Equityholder Representative, LLCJoinder to Guarantee and Collateral Assignment
Mar 27, 2017
Reel 41754, frame 517
Interpace Diagnostics Group, Inc.Hudson Bay Master Fund Ltd.Security Interest
Jun 16, 2017
Reel 42840, frame 860
Hudson Bay Master Fund Ltd.Interpace Diagnostics Group, Inc.; Interpace Biopharma, LLC; Interpace Diagnostics, LLC; Interpace Diagnostics Lab, Inc.; Interpace Diagnostics CorporationRelease of Security Interest
Jun 16, 2017
Reel 42856, frame 799
Hudson Bay Master Fund Ltd.Interpace Diagnostics Group, Inc.; Interpace Diagnostics, LLC; Interpace Diagnostics CorporationRelease of Security Interest
Jun 16, 2017
Reel 42858, frame 971
Hudson Bay Master Fund Ltd.Interpace Diagnostics CorporationRelease of Security Interest
Jun 16, 2017
reel/frame not recorded
Hudson Bay Master Fund Ltd.Interpace Diagnostics Group, Inc.Release of Security Interest
Jun 16, 2017
reel/frame not recorded
Hudson Bay Master Fund Ltd.Interpace Biopharma, LLCRelease of Security Interest
Jun 16, 2017
reel/frame not recorded
Hudson Bay Master Fund Ltd.Interpace Diagnostics, LLCRelease of Security Interest
Jun 16, 2017
reel/frame not recorded
Hudson Bay Master Fund Ltd.Interpace Diagnostics Lab, Inc.Release of Security Interest
Oct 20, 2021
Reel 57851, frame 305
Interpace Diagnostics, LLCComerica BankSecurity Interest
Nov 2, 2021
Reel 57988, frame 110
Interpace Biosciences, Inc.; Interpace Diagnostics Corporation; Interpace Diagnostics, LLC; Interpace Pharma Solutions, Inc.Broadoak Fund V, L.p.Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited